TUMOR SEEKING PEPTIDE RECEPTOR RADIOPHARMACEUTICALS

肿瘤寻找肽受体放射性药物

• 批准号: 6665898
• 负责人: Wynn A Volkert
• 金额: $ 15.75万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-08-01 至 2003-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6665898
• 关键词: animal tissue; biological products; biomedical resource; drug adverse effect; environmental toxicology; liver; neoplasm /cancer; spectrometry; urinary tract

Mass spectral analyses of peptides and ligands synthesized in our laboratory are essential to confirm that the compounds are peptides and have the expected molecular weights. Confirmation by mass spectrometry will allow biological and other chemical studies to proceed.

我们在我们的中合成的肽和配体的质谱分析 实验室必须确认化合物是肽 并具有预期的分子量。 通过质量确认 光谱法将允许生物学和其他化学研究 继续。